![Report France - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights for 499$](/landing/img/reports/france-hormones-prostaglandins-thromboxanes-and-leukotrienes-market-analysis-forecast-size-trends-and-insights.webp)
France - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingFrance: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024
Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in France
The French market for hormones, prostaglandins, thromboxanes and leukotrienes reduced markedly to $X in 2023, dropping by X% against the previous year. Overall, consumption showed a abrupt setback. As a result, consumption attained the peak level of $X. From 2018 to 2023, the growth of the market remained at a lower figure.
Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in France
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production skyrocketed to $X in 2023 estimated in export price. Over the period under review, production, however, saw a drastic downturn. The most prominent rate of growth was recorded in 2015 with an increase of X% against the previous year. Over the period under review, production attained the peak level at $X in 2012; however, from 2013 to 2023, production stood at a somewhat lower figure.
Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Exports from France
In 2023, after two years of growth, there was significant decline in overseas shipments of hormones, prostaglandins, thromboxanes and leukotrienes, when their volume decreased by X% to X tons. In general, exports saw a abrupt curtailment. The most prominent rate of growth was recorded in 2022 when exports increased by X%. The exports peaked at X tons in 2012; however, from 2013 to 2023, the exports stood at a somewhat lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports contracted modestly to $X in 2023. Overall, exports continue to indicate a pronounced setback. The most prominent rate of growth was recorded in 2015 with an increase of X%. As a result, the exports attained the peak of $X. From 2016 to 2023, the growth of the exports remained at a lower figure.
Exports by Country
The UK (X tons), Germany (X tons) and Italy (X tons) were the main destinations of hormones, prostaglandins, thromboxanes and leukotrienes exports from France, together accounting for X% of total exports. The Czech Republic, Spain, Austria, the United States, Sweden, India, China, Japan, Morocco and Belgium lagged somewhat behind, together accounting for a further X%.
From 2012 to 2023, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by the Czech Republic (with a CAGR of X%), while the other leaders experienced more modest paces of growth.
In value terms, the largest markets for hormones, prostaglandins, thromboxanes and leukotrienes exported from France were the United States ($X), Sweden ($X) and Austria ($X), together comprising X% of total exports. Italy, Spain, the UK, Germany, Japan, India, Belgium, Morocco, the Czech Republic and China lagged somewhat behind, together comprising a further X%.
In terms of the main countries of destination, China, with a CAGR of X%, recorded the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
The average export price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2023, jumping by X% against the previous year. In general, the export price saw a measured expansion. The most prominent rate of growth was recorded in 2020 an increase of X%. Over the period under review, the average export prices reached the maximum at $X per kg in 2017; however, from 2018 to 2023, the export prices failed to regain momentum.
There were significant differences in the average prices for the major export markets. In 2023, amid the top suppliers, the country with the highest price was Sweden ($X per kg), while the average price for exports to the Czech Republic ($X per kg) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to the United States (X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Imports into France
Hormones, prostaglandins, thromboxanes and leukotrienes imports into France contracted sharply to X tons in 2023, which is down by X% on the previous year's figure. Overall, imports saw a noticeable curtailment. The most prominent rate of growth was recorded in 2017 when imports increased by X% against the previous year. As a result, imports reached the peak of X tons. From 2018 to 2023, the growth of imports remained at a somewhat lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports shrank rapidly to $X in 2023. Over the period under review, imports continue to indicate a abrupt descent. The most prominent rate of growth was recorded in 2017 when imports increased by X%. As a result, imports attained the peak of $X. From 2018 to 2023, the growth of imports failed to regain momentum.
Imports by Country
In 2023, China (X tons) constituted the largest hormones, prostaglandins, thromboxanes and leukotrienes supplier to France, accounting for a X% share of total imports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes imports from China exceeded the figures recorded by the second-largest supplier, the United States (X tons), eightfold. Belgium (X tons) ranked third in terms of total imports with a X% share.
From 2012 to 2023, the average annual growth rate of volume from China amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (X% per year) and Belgium (X% per year).
In value terms, the largest hormones, prostaglandins, thromboxanes and leukotrienes suppliers to France were the United States ($X), Belgium ($X) and Austria ($X), together accounting for X% of total imports.
Belgium, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
The average import price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2023, reducing by X% against the previous year. Overall, the import price recorded a noticeable decline. The most prominent rate of growth was recorded in 2021 an increase of X% against the previous year. The import price peaked at $X per kg in 2014; however, from 2015 to 2023, import prices stood at a somewhat lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was Belgium ($X per kg), while the price for China ($X per kg) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by the Netherlands (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in France. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21105200 - Hormones, prostaglandins, thromboxanes and leukotrienes, n atural or reproduced by synthesis, derivatives and structural analogues thereof, including chain modified polypeptides, u sed primarily as hormones
Country coverage:
- France
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in France
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Asia.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the U.S..
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in China.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the EU.
This report provides an in-depth analysis of the global market for hormones, prostaglandins, thromboxanes and leukotrienes.
- Market Research in France
- Price for Hormones, Prostaglandins, Thromboxanes and Leukotrienes France
- Hormones Market
- Sterile Medical Adhesion Barrier Market
- Glycosides and Vegetable Alkaloids Market
- Antibiotic Market
- Organ Extracts Market
- Antisera Market
- Biological Product Market
- Veterinary Medicine Vaccines Market